186 related articles for article (PubMed ID: 33401207)
1. Synthetic 1,4-Naphthoquinones inhibit P2X7 receptors in murine neuroblastoma cells.
Pislyagin E; Kozlovskiy S; Menchinskaya E; Chingizova E; Likhatskaya G; Gorpenchenko T; Sabutski Y; Polonik S; Aminin D
Bioorg Med Chem; 2021 Feb; 31():115975. PubMed ID: 33401207
[TBL] [Abstract][Full Text] [Related]
2. P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones.
de Luna Martins D; Borges AA; E Silva NADA; Faria JV; Hoelz LVB; de Souza HVCM; Bello ML; Boechat N; Ferreira VF; Faria RX
Bioorg Chem; 2020 Nov; 104():104278. PubMed ID: 33010623
[TBL] [Abstract][Full Text] [Related]
3. 1,4-Naphthoquinones potently inhibiting P2X7 receptor activity.
Faria RX; Oliveira FH; Salles JP; Oliveira AS; von Ranke NL; Bello ML; Rodrigues CR; Castro HC; Louvis AR; Martins DL; Ferreira VF
Eur J Med Chem; 2018 Jan; 143():1361-1372. PubMed ID: 29133043
[TBL] [Abstract][Full Text] [Related]
4. 8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages.
Pacheco PAF; Galvão RMS; Faria AFM; Von Ranke NL; Rangel MS; Ribeiro TM; Bello ML; Rodrigues CR; Ferreira VF; da Rocha DR; Faria RX
Bioorg Med Chem; 2019 Apr; 27(8):1449-1455. PubMed ID: 30528164
[TBL] [Abstract][Full Text] [Related]
5. Anti-Inflammatory Activity of 1,4-Naphthoquinones Blocking P2X7 Purinergic Receptors in RAW 264.7 Macrophage Cells.
Kozlovskiy SA; Pislyagin EA; Menchinskaya ES; Chingizova EA; Sabutski YE; Polonik SG; Likhatskaya GN; Aminin DL
Toxins (Basel); 2023 Jan; 15(1):. PubMed ID: 36668867
[TBL] [Abstract][Full Text] [Related]
6. Tetracyclic 1,4-Naphthoquinone Thioglucoside Conjugate U-556 Blocks the Purinergic P2X7 Receptor in Macrophages and Exhibits Anti-Inflammatory Activity In Vivo.
Kozlovskiy S; Pislyagin E; Menchinskaya E; Chingizova E; Kaluzhskiy L; Ivanov AS; Likhatskaya G; Agafonova I; Sabutski Y; Polonik S; Manzhulo I; Aminin D
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569745
[TBL] [Abstract][Full Text] [Related]
7. Discovery of bilirubin as novel P2X7R antagonist with anti-tumor activity.
Zhao Y; Chen X; He C; Gao G; Chen Z; Du J
Bioorg Med Chem Lett; 2021 Nov; 51():128361. PubMed ID: 34543755
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays.
Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J
Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Biological Evaluation and Molecular Modeling Studies of Naphthoquinone Sulfonamides and Sulfonate Ester Derivatives as P2X7 Inhibitors.
Pacheco PAF; Gonzaga DTG; von Ranke NL; Rodrigues CR; da Rocha DR; da Silva FC; Ferreira VF; Faria RX
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677652
[TBL] [Abstract][Full Text] [Related]
10. Arylboronic acids inhibit P2X7 receptor function and the acute inflammatory response.
Faria RX; de Jesus Hiller N; Salles JP; Resende JALC; Diogo RT; von Ranke NL; Bello ML; Rodrigues CR; Castro HC; de Luna Martins D
J Bioenerg Biomembr; 2019 Aug; 51(4):277-290. PubMed ID: 31256283
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Cytotoxic Activity Evaluation and Quantitative Structure-Activity Analysis of Substituted 5,8-Dihydroxy-1,4-Naphthoquinones and their
Polonik S; Likhatskaya G; Sabutski Y; Pelageev D; Denisenko V; Pislyagin E; Chingizova E; Menchinskaya E; Aminin D
Mar Drugs; 2020 Nov; 18(12):. PubMed ID: 33260299
[TBL] [Abstract][Full Text] [Related]
12. P2X7 receptors: channels, pores and more.
Volonté C; Apolloni S; Skaper SD; Burnstock G
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):705-21. PubMed ID: 22963440
[TBL] [Abstract][Full Text] [Related]
13. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.
Di Virgilio F; Jiang LH; Roger S; Falzoni S; Sarti AC; Vultaggio-Poma V; Chiozzi P; Adinolfi E
Methods Enzymol; 2019; 629():115-150. PubMed ID: 31727237
[TBL] [Abstract][Full Text] [Related]
14. Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists.
Caseley EA; Muench SP; Fishwick CW; Jiang LH
Biochem Pharmacol; 2016 Sep; 116():130-9. PubMed ID: 27481062
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells.
Kwak SH; Shin S; Lee JH; Shim JK; Kim M; Lee SD; Lee A; Bae J; Park JH; Abdelrahman A; Müller CE; Cho SK; Kang SG; Bae MA; Yang JY; Ko H; Goddard WA; Kim YC
Eur J Med Chem; 2018 May; 151():462-481. PubMed ID: 29649742
[TBL] [Abstract][Full Text] [Related]
16. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor.
Hempel C; Nörenberg W; Sobottka H; Urban N; Nicke A; Fischer W; Schaefer M
Neuropharmacology; 2013 Dec; 75():365-79. PubMed ID: 23954492
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of naphthoquinone phenacylimidazolium derivatives.
Yuan J; Liu Z; Zhang Z; Yan D; Zhang W
Bioorg Med Chem Lett; 2021 Jun; 41():127977. PubMed ID: 33766771
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and anticancer activity of naphthoquinone derivatives.
Shen XB; Wang Y; Han XZ; Sheng LQ; Wu FF; Liu X
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):773-785. PubMed ID: 32200656
[TBL] [Abstract][Full Text] [Related]
19. Target ROS to induce apoptosis and cell cycle arrest by 5,7-dimethoxy-1,4-naphthoquinone derivative.
Li K; Wang B; Zheng L; Yang K; Li Y; Hu M; He D
Bioorg Med Chem Lett; 2018 Feb; 28(3):273-277. PubMed ID: 29305189
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship studies of pyrimidine-2,4-dione derivatives as potent P2X7 receptor antagonists.
Park JH; Lee GE; Lee SD; Ko H; Kim YC
Eur J Med Chem; 2015 Dec; 106():180-93. PubMed ID: 26547056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
